Skip to main content
. 2000 Oct 21;321(7267):983. doi: 10.1136/bmj.321.7267.983

Figure 1.

Figure 1

Effect of lipid lowering drugs (compared with placebo) on odds of coronary heart disease events, coronary heart disease mortality, and all cause mortality (fixed effects model). LRC=Lipid Research Clinic primary prevention trial; HHS=Helsinki heart study; WOSCOPS=west of Scotland coronary prevention study; AFCAPS/TexCAPS=air force/Texas coronary prevention study